Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Subramaniam Kugathasan

Pediatric Gastroenterology Atlanta, GA Medical Doctor

NPI 1497706238 CMS profile 1117661

1400 Tullie Rd Ne Fl 2, Atlanta, GA 30329

Open in the dashboard

General payments

$47,330

40 records reported · program years 2019–2025

Research payments

$56,632

Paid to them · 11 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$930,071 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Subramaniam Kugathasan of Atlanta, GA is reported in the CMS Open Payments database as having received $47,330 across 40 general payments and $56,632 in research payments paid to them. Separately, studies naming them as principal investigator received $930,071 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $27,938 27
2025 Research $1,913 1
2024 General $5,340 3
2024 Research $2,040 1
2023 General $1,100 1
2022 General $1,100 1
2021 General $5,850 3
2021 Research $44,010 6
2020 General $67 1
2020 Research $6,120 2
2019 General $5,935 4
2019 Research $2,550 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Subramaniam Kugathasan
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Subramaniam Kugathasan were reported at $27,938. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Subramaniam Kugathasan Pediatric Gastroenterology median Middle half National median
2019 $5,935 $131 $41–$311 $163
2020 $67 $79 $23–$223 $114
2021 $5,850 $104 $32–$321 $132
2022 $1,100 $125 $37–$331 $149
2023 $1,100 $169 $55–$440 $160
2024 $5,340 $196 $73–$563 $164
2025 $27,938 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Scientific Affairs, LLC $17,252 10 payments
  2. Celltrion USA Inc. $13,496 19 payments
  3. Takeda Pharmaceuticals U.S.A., Inc. $12,240 5 payments
  4. Ucb SA $2,700 1 payment
  5. AbbVie, Inc. $1,535 2 payments
  6. Janssen Biotech, Inc. $85 2 payments
  7. Organon LLC $23 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $32,040 14 payments
  2. Honoraria $13,040 1 payment
  3. Grant $1,500 1 payment
  4. Food and Beverage $683 23 payments
  5. Education $67 1 payment
Products named General payments · program years 2019–2025
  1. REMICADE $17,100 8 payments
  2. ZYMFENTRA $13,066 10 payments
  3. Entyvio $3,060 1 payment
  4. Cimzia $2,700 1 payment
  5. VEGZELMA $430 9 payments
  6. STELARA $192 2 payments
  7. TREMFYA $45 2 payments
  8. SKYRIZI $35 1 payment
  9. RENFLEXIS $23 1 payment
  10. HADLIMA $23 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Eli Lilly and Company $37,830 2 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $17,703 8 payments
  3. AbbVie, Inc. $1,100 1 payment

Records

51 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Gastroenterology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record